Scholarlink

Purpose <p>This scoping&#xa0;review examines strategies to improve adhesion and integration of epicardial patches within the dynamic and wet cardiac environment. It emphasizes mucin-based bioadhesives and auxetic designs as potential solutions for long-term tissue-conformal myocardial repair.</p> Methods <p>Approximately 150 peer-reviewed articles published between 2010 and 2024 were identified through a structured literature search conducted across PubMed, Scopus, and Web of Science. The studies cover adhesive biomaterials, structural patch designs, and epicardial tissue repair approaches&#xa0;were screened and thematically synthesized to map current advances, limitations, and translational gaps.</p> Results <p>Commercially available epicardial patches fail to maintain adhesion under cyclic loading and fluid-rich conditions. Among bioadhesives, mucin demonstrates promising wet adhesion, viscoelasticity, and biocompatibility. Nonetheless, its translation is limited by batch-to-batch variability, purification challenges, and potential immunogenicity. Dopamine-, hyaluronic acid-, and alginate-based adhesives provide alternatives but remain constrained by oxidative instability, limitted long-term durability, or inadequate mechanical performance. Structural innovations such as auxetic geometries improve patch flexibility, strain distribution, and conformability compared with multilayered or microneedle-based strategies. However, challenges related to fabrication, sterilization, scalability and potential interference of cardiac anatomy andphysiology require further investigation.</p> Conclusions <p>The synergistic integration of mucin-based adhesives with auxetic designs presents a compelling pathway toward durable, biocompatible, and tissue-conformal cardiac patches. Addressing manufacturing scalability, reproducibility, and immunological safety will be critical to advancing these concepts toward clinical applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mucin-Based Biomimetic Patches for Dynamic Heart Repair: Auxetic Structures and Translational Challenges

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月26日

查看全文
  • Rishatani Gunasegaran,
  • Rania Hussien Al-Ashwal,
  • Norhana Jusoh,
  • Muhammad Hanif Ramlee,
  • Sadeq M. Al-Hazmy

摘要

Purpose

This scoping review examines strategies to improve adhesion and integration of epicardial patches within the dynamic and wet cardiac environment. It emphasizes mucin-based bioadhesives and auxetic designs as potential solutions for long-term tissue-conformal myocardial repair.

Methods

Approximately 150 peer-reviewed articles published between 2010 and 2024 were identified through a structured literature search conducted across PubMed, Scopus, and Web of Science. The studies cover adhesive biomaterials, structural patch designs, and epicardial tissue repair approaches were screened and thematically synthesized to map current advances, limitations, and translational gaps.

Results

Commercially available epicardial patches fail to maintain adhesion under cyclic loading and fluid-rich conditions. Among bioadhesives, mucin demonstrates promising wet adhesion, viscoelasticity, and biocompatibility. Nonetheless, its translation is limited by batch-to-batch variability, purification challenges, and potential immunogenicity. Dopamine-, hyaluronic acid-, and alginate-based adhesives provide alternatives but remain constrained by oxidative instability, limitted long-term durability, or inadequate mechanical performance. Structural innovations such as auxetic geometries improve patch flexibility, strain distribution, and conformability compared with multilayered or microneedle-based strategies. However, challenges related to fabrication, sterilization, scalability and potential interference of cardiac anatomy andphysiology require further investigation.

Conclusions

The synergistic integration of mucin-based adhesives with auxetic designs presents a compelling pathway toward durable, biocompatible, and tissue-conformal cardiac patches. Addressing manufacturing scalability, reproducibility, and immunological safety will be critical to advancing these concepts toward clinical applications.